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We	 identified	 the	near-full-genome	sequence	 (29,908	
nt,	>99%)	of	Middle	East	respiratory	syndrome	coronavirus	
(MERS-CoV)	 from	a	nasal	swab	specimen	from	a	drome-
dary	camel	in	Egypt.	We	found	that	viruses	genetically	very	
similar	 to	 human	 MERS-CoV	 are	 infecting	 dromedaries	
beyond	 the	Arabian	Peninsula,	where	human	MERS-CoV	
infections	have	not	yet	been	detected.
Middle East respiratory syndrome (MERS) is a pneu-monic illness caused by a novel lineage C beta-
coronavirus (CoV). During September 2012–January 20, 
2014, a total of 178 confirmed cases in humans resulted 
in 76 deaths (1). Primary infections have originated from 
countries within the Arabian Peninsula, although travel-
associated cases and some secondary transmission have 
been reported in other countries. Limited human-to-human 
transmission has resulted in clusters of cases, some associ-
ated with multiple rounds of human-to-human transmission 
(2); the remaining sporadic cases in humans are presumed 
to be of zoonotic origin.
MERS-CoV genomes are phylogenetically classified 
into 2 clades, clade A and B clusters (3). The viral genomes 
detected in the earliest cases in humans (clade A cluster; 
EMC/2012 and Jordan-N3/2012) are genetically distinct 
from the others (i.e., clade B). The proximate source of hu-
man infection remains unclear. MERS-CoV is related to, 
but not identical to, viruses detected in bats (4,5). A short 
RNA fragment of the conserved viral polymerase region 
identical to MERS-CoV has been identified in Taphozous 
perforates bats, but these findings need to be confirmed (6).
Serologic studies of domestic livestock in Jordan, Sau-
di Arabia, Qatar, United Arab Emirates, and Egypt have 
found high seroprevalance to a MERS-like CoV in drom-
edary camels but not in other domestic animals (7–11). 
An investigation of domestic animals in the vicinity of 2 
persons with related infections detected fragments of viral 
RNA in dromedary camels in contact with these persons 
but whether this represented transmission from a unidenti-
fied source to humans and dromedaries, transmission from 
humans to dromedaries, or vice versa is not clear (12).
The Study
We collected nasal swab specimens from 110 appar-
ently healthy dromedaries (Camelus dromedarius) >6 
years of age in abattoirs on 12 occasions during June–De-
cember 2013 (Table 1). Serum was collected from 52 of 
these dromedaries. Serum from 179 persons working in 
the camel abattoirs also was collected. Median age of these 
workers was 38 years (range 9–67 years), 84% were male, 
and 25 reported comorbidities (i.e., cardiovascular, renal, 
diabetes, other). Collection of the human specimens was 
approved by the ethics committee of the National Research 
Centre (Giza, Egypt), and Institutional Animal Care and 
Use Committee approval for collection of animal samples 
was obtained from St Jude Children’s Research Hospital 
(Memphis, TN, USA).
Real-time reverse transcription PCR (RT-PCR) tar-
geting upstream of E gene of MERS-CoV was used for 
screening. The open reading frame (ORF) 1a gene was used 
for confirmation as recommended by the World Health 
Organization(www.who.int/csr/disease/coronavirus_ 
infections/MERS_Lab_recos_16_Sept_2013.pdf?ua=1). 
We also used a previously described pan-CoV nested 
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Table	1.	Results	of	testing	nasal	swab	specimens	from	
dromedary	camels	by	RT-PCR	for	MERS-CoV	and	for	other	
CoVs,	Egypt,	2013* 
Location	of	animals	
sampled 
No.	
samples 
tested 
No.	MERS-
CoV	
positive† 
No.	other	CoV	
positive.	(virus	
identified) 
Alexandria‡ 17 0 0 
Cairo    
 Abattoir 1§ 46 0 3	(BCoV) 
 Abattoir 2§ 10 3 0 
Nile	Delta	region,	
abattoir§ 
37 1 5	(BCoV) 
*RT-PCR,	reverse	transcription	PCR;	MERS,	Middle	East	respiratory	
syndrome;	CoV,	coronavirus;	BCoV,	bovine	coronavirus. 
Nasal	swabs	from	dromedary	camels	were	placed	in	phosphate-buffered 
saline/glycerol	transport	medium,	kept	on	ice	during	the	field	trip	and	
stored at 80°C	on	arriving	at	the	laboratory.	Specimens	were	shipped	in	
dry	ice	to	the	University	of	Hong	Kong	laboratory, where they were stored 
at 80°C until testing. 
†Taken as positive only when both upstream of E gene and open reading 
frame	1a	RT-PCR	were	positive. 
‡Locally reared animals. 
§Imported from Sudan or Ethiopia. 
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PCR targeting the viral RNA-dependent RNA polymerase 
(RdRp) region (13), and PCR products were analyzed by 
sequencing (online Technical Appendix, wwwnc.cdc.gov/
EID/article/20/6/14-0299-Techapp1.pdf).
We detected MERS-CoV RNA in 4 (3.6%) of 110 nasal 
swab specimens from dromedary camels with the upstream 
of E gene assay (cycle threshold [Ct] 23.2–36.8), confirmed 
by the ORF1a assay (Ct 23.2–39.1), fulfilling the World 
Health Organization criteria for diagnosis of MERS-CoV 
infection (Table 1). PCR was repeated from a fresh RNA 
extract to confirm positive results. One positive sample 
was obtained from a camel in an abattoir in the Nile Delta 
region in November 2013 and 3 other samples from an ab-
attoir in Cairo in December 2013. Virus culture attempts 
in Vero E6 cells (ATCC CRL-1586) so far have been un-
successful. The pan-CoV nested PCR detected CoV in an 
additional 8 specimens from dromedary camels. Sequence 
analyses of these additional positive samples showed that 
these amplicon sequences were genetically similar to those 
of bovine coronavirus (BCoV) (>99% nucleotide simi-
larity). No animal was co-infected with MERS-CoV and 
BCoV-like viruses. The animals positive for either MERS-
CoV or BCoV-like virus were all imported from Sudan or 
Ethiopia for slaughter.
Figure	1.	Phylogenetic	analyses	of	a	partial	RNA-dependent	RNA	polymerase	(RdRp)	sequence	determined	from	samples	from	dromedary	
camels	(Camelus dromedarius)	NRCE-HKU205	and	NRCE-HKU270	that	were	positive	for	Middle	East	respiratory	syndrome	coronavirus	
(MERS-CoV).	The	viral	RdRp	region	analyzed	is	a	highly	conserved	region	of	the	genome	(covering	motif	B	of	RdRp)	in	nonstructural	protein	
12,	at	position	15202–15582	of	MERS-CoV	genome.	The	partial	RdRp	sequence	of	NRCE-HKU205	(GenBank	accession	no.	KJ477102)	
and	 NRCE-HKU270	 (GenBank	 accession	 no.	 KJ477103)	 was	 aligned	 with	 human	MERS-CoVs	 (GenBank	 accession	 nos.	 KF600652,	
KF600630,	KF600651,	KF186567,	KF600627,	KF186564,	KF600634,	KF600632,	KF600644,	KF600647,	KF600645,	KF186565,	KF186566,	
KF745068,	 KF600620,	 KF600612,	 KC667074,	 KC164505,	 KF192507,	 KF600613,	 KF600628,	 KF961222,	 KF961221,	 KC776174,	 and	
JX869059)	 and	other	 representative	animal	 betacoroanviruses	 (GenBank	accession	nos.	HKU5–1,	EF065509;	BtCoV/PML/Neo	 cf.	 zul/
RSA/2011,	KC869678).	Bat	CoV	HKU5–1	and	bat	CoV/PML/Neo	cf.	zul/RSA/2011	were	 included	 in	 the	analysis	as	outgroups	because	
they	are	phylogenetically	closest	to	MERS-CoV.	Phylogenetic	trees	were	constructed	by	using	MEGA5	(14)	with	neighbor-joining	method.	
Numbers	at	nodes	 indicate	bootstrap	values	determined	by	500	 replicates.	Only	bootstrap	values	>70	are	denoted.	Bold	 type	 indicates	
MERS-CoV	identified	in	the	current	study.	Scale	bars	indicate	the	estimated	genetic	distance	of	these	viruses.
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On phylogenetic analysis, the partial RdRp sequences 
from MERS-CoV–positive samples NRCE-HKU205 and 
NRCE-HKU270 grouped within the cluster of MERS-
CoV (Figure 1). The viral load in the other 2 specimens 
was too low to provide amplicons suitable for genetic 
sequencing. Viral RNA from NRCE-HKU205, the first 
positive specimen detected, was selected for more de-
tailed genomic sequencing. We amplified viral RNA 
by PCR, using primers specific for overlapping regions 
of human MERS-CoV genome. PCR products were se-
quenced and assembled to produce a near full-length 
genome, lacking only the 3′ untranslated region (29908 
nt, >99% of the MERS-CoV genome) (online Technical 
Appendix). The camel MERS-CoV genome has an over-
all nucleotide similarity of 99.2%−99.5% and deduced 
amino acid similarity of 98.0%–100% to ORFs of human 
MERS-CoV EMC/2012 (Table 2). The 5′ untranslated re-
gion and internal transcriptional regulatory sequences of 
NRCE-HKU205 were identical to published human 
MERS-CoV sequences.
Using MERS-CoV EMC/2012 as a reference sequence, 
we found 12 aa differences (residues 23, 26, 194, 434, 666, 
696, 756, 886, 888, 918, 1158, and 1333 of EMC/2012) 
in the spike protein of dromedary MERS-CoV NRCE-
HKU205 and 1 aa deletion (residue 1293 of EMC/2012) 
in the N terminal of the transmembrane domain. NRCE-
HKU270 virus spike does not have a deletion of residue 
1293. Of these, only residue 434 falls within the proposed 
receptor binding domain of spike protein, but it is located 
at the core (stem) subdomain of the receptor binding do-
main, suggesting that the camel MERS-CoV is still likely 
to bind human CD26 (online Technical Appendix Figure). 
The biological impact of this difference and other amino 
acid differences needs to be fully explored.
We used phylogenetic analyses of the full genome, 
the spike gene, and nucleocapsid gene of MERS-CoV 
NRCE-HKU205 to compare with the same genes of other 
human MERS-CoVs (Figure 2). NRCE-HKU205 is 
within the clade A group but distinct from MERS-CoV 
EMC/2012, the only other MERS-CoV isolate available 
in our laboratory, excluding laboratory cross-contamina-
tion as an explanation for the detection of MERS-CoV 
from the dromedary specimens.
Using a previously described pseudoparticle neutral-
ization assay (8), we detected antibodies against MERS-
CoV (titer >20) in 48 (92.3%) of 52 dromedary serum 
samples with titers ranging from 20 to >640. Dromedary 
NRCE-HKU205 had a serum antibody titer of 640, possi-
bly indicating a developing serologic response, as was not-
ed previously (7), or the possibility of re-infection. Serum 
was not available from the other 3 animals with MERS-
CoV RNA-positive nasal swab specimens.
Serum from 179 persons working in the dromedary ab-
attoirs was negative for antibody to MERS-CoV. This find-
ing includes 114 persons working in the 2 abattoirs from 
which the MERS-CoV–positive animal swab specimens 
were obtained.
Conclusions
Our findings confirm that MERS-CoV infects drom-
edary camels and that this virus is genetically very similar 
to a MERS-CoV that is infecting humans. The detection 
of MERS-CoV in nasal swab specimens of camels in 2 of 
12 sampling occasions in abattoirs, taken together with the 
high seropositivity to MERS-CoV in dromedaries previ-
ously reported, supports the contention that MERS-CoV 
infection is common in dromedaries. Studies of drom-
edaries within camel herds and through the animal mar-
keting system supplying abattoirs are needed to define the 
epidemiology of the infection. Our findings strengthen the 
plausibility that dromedaries may be a potential source of 
human infection and emphasize the need for detailed epide-
miologic investigation of the exposure histories of humans 
with MERS. However, the lack of serologic evidence of in-
fection of humans working in these abattoirs suggests that 
transmission of this virus to humans is uncommon. The de-
tection of MERS-CoV in dromedaries in Egypt, in animals 
imported from Sudan and Ethiopia, suggests that cases may 
occur in humans beyond the Arabian Peninsula. MERS 
CoV diagnostic tests should be considered for all patients 
with unexplained severe pneumonia in Egypt, northeastern 
Africa, and beyond.
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Table	2.	Percentage	identity	between	ORFs	of	dromedary	camel	
MERS-CoV	(NRCE-HKU205)	and	human	MERS-CoV	
(EMC/2012)	at	the	nucleotide	and	amino	acid	levels* 
ORF 
% Identity	to	HCoV-EMC/2012 
Nucleotide Amino acid 
ORF1a 99.5 99.2 
ORF1b 99.5 99.7 
S 99.2 98.9 
ORF3 99.0 98.0 
ORF4a 99.0 100 
ORF4b 99.4 99.1 
ORF5 99.4 98.6 
E 100 100 
M 100 100 
N 99.4 99.2 
ORF8b 99.1 98.2 
*ORF,	open	reading	frame;	MERS,	Middle	East	respiratory	syndrome;	
CoV,	coronavirus;	H,	human; E,	envelope;	M,	membrane;	N,	nucleocapsid. 
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